Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.57 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.55 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.55 |
| ▸ | BCHE | P06276 | 5/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 3/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | MAOA | P21397 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2643014 | 0.82 | MIF (0.50) | LMNASLC6A2SLC6A3HIF1AMAOB | |
| SCHEMBL10609652 | 0.78 | LMNA (0.75) | LTA4HEPHX2FFAR1FFAR4BCHE | |
| SCHEMBL27367676 | 0.78 | LMNA (0.82) | LTA4HEPHX2BCHELMNACYP1A2 | |
| SCHEMBL339813 | 0.78 | LMNA (0.82) | LTA4HEPHX2BCHELMNACYP1A2 | |
| SCHEMBL6430720 | 0.78 | FFAR1 (0.56) | LTA4HEPHX2FFAR1FFAR4BCHE | |
| SCHEMBL12630258 | 0.77 | LTA4H (0.77) | LTA4HEPHX2FFAR1FFAR4BCHE | |
| SCHEMBL12040562 | 0.77 | LTA4H (0.77) | LTA4HEPHX2FFAR1FFAR4BCHE | |
| SCHEMBL5599 | 0.77 | LTA4H (0.66) | LTA4HEPHX2FFAR1FFAR4BCHE | |
| SCHEMBL26914698 | 0.77 | LMNA (0.53) | LTA4HEPHX2FFAR1FFAR4BCHE | |
| SCHEMBL3421201 | 0.75 | LMNA (0.85) | LTA4HEPHX2FFAR1FFAR4BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2563757-B1 | METHOD FOR PREPARING RITODRINE HYDROCHLORIDE | LUNDBECK PHARMACEUTICALS ITALY S P A (IT) | 2016-11-16 | — | — | EP | disclosed |
| US-8912360-B2 | Methods for preparing ritodrine hydrochloride | LUNDBECK PHARMACEUTICALS ITALY S.P.A. (IT) | 2014-12-16 | — | — | US | disclosed |
| US-20130123539-A1 | METHODS FOR PREPARING RITODRINE HYDROCHLORIDE | LUNDBECK PHARMACEUTICALS ITALY S.P.A. (IT) | 2013-05-16 | — | — | US | disclosed |
| EP-2563757-A2 | METHOD FOR PREPARING RITODRINE HYDROCHLORIDE | Lundbeck Pharmaceuticals Italy S.p.A. (IT) | 2013-03-06 | — | — | EP | disclosed |
| WO-2011134724-A2 | METHOD FOR PREPARING RITODRINE HYDROCHLORIDE | LUNDBECK PHARMACEUTICALS ITALY S.P.A. (IT) | 2011-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130123539-A1 | METHODS FOR PREPARING RITODRINE HYDROCHLORIDE | COMT, ADRA2C, ADRA1D | LTA4H 1699/4885EPHX2 354/4885FFAR1 3236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.